Mariner
ADMA icon

Mariner’s ADMA Biologics ADMA Stock Holding History

Mariner’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
178,752
+149,198
+505% +$1.36M ﹤0.01% 1669
2026
Q1 		$266K Sell
29,554
-40,388
-58% -$637K ﹤0.01% 2973
2025
Q4 		$1.28M Buy
69,942
+31,569
+82% +$532K ﹤0.01% 1777
2025
Q3 		$563K Buy
38,373
+9,297
+32% +$159K ﹤0.01% 2333
2025
Q2 		$529K Buy
29,076
+7,584
+35% +$155K ﹤0.01% 2287
2025
Q1 		$426K Sell
21,492
-11,927
-36% -$206K ﹤0.01% 2333
2024
Q4 		$573K Buy
+33,419
New +$629K ﹤0.01% 2079

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mariner's ADMA Position: Q2 2026 in Review

Mariner increased its ADMA Biologics (ADMA) stake by 505% in Q2 2026, buying an estimated $1.36M and bringing the position to 178,752 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1669.

Mariner first reported a position in ADMA in Q4 2024 and has held it in 7 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Mariner held 178,752 shares of ADMA Biologics worth $1.5M as of Q2 2026.
  • Mariner bought 149,198 ADMA Biologics shares in Q2 2026, an estimated $1.36M.
  • ADMA Biologics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1669 holding.
  • Mariner first reported a position in ADMA Biologics in Q4 2024 and has held it in 7 quarters since.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.